National Association of Testing Authorities, Australia
Scope of Accreditation
Australian Red Cross Lifeblood
Site
Melbourne Processing Centre – Manufacturing
Accreditation No.
18808
Site No.
22664
Date of Accreditation
26 Jun 1985
Contact
Mr Andrew Tracy
P: +61 (03) 92520990
Availability
Services available to external clients
Supervision
Not Applicable
Scope of Accreditation
Melbourne Processing Centre – Manufacturing
ISO 15189 (2022)
- This facility complies with the relevant National Pathology Accreditation Advisory Council (NPAAC) requirements.
Human Pathology
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Investigation and determination of hepatic, cardiac, bone, skeletal muscle and other profiles and metabolic studies | Serum | Ferritin |
| Haematology - Full blood examination | Blood | Differential number; Erythrocyte count (red blood cell count, RBCC); Haematocrit (packed cell volume, PCV); Haemoglobin (Hb); Leucocyte count (white blood cell count, WBCC); Platelet count; Red blood cell index or indices |
| Immunohaematology - Blood group antibody detection | Blood; Plasma; Serum | Duffy system; Kell system; M and N factors; Other blood group systems; Rh phenotypes |
| Immunohaematology - Blood grouping | Blood; Plasma; Serum | ABO; RhD |
| Immunohaematology - Identification and quantitation of blood group antibodies | Blood; Plasma; Serum | High titre anti-A and anti-B screening |
| Red blood cell phenotyping | ||
| Microbiology - Bacteriology - Detection of pathogenic bacteria | Plasma; Plasma derivatives; Platelet concentrates; Red cell concentrates; Serum | Bacteria; Pathogenic microorganisms |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (viruses) | Cadaveric donor | Hepatitis B virus (HBV) DNA; Hepatitis C virus (HCV) viral RNA; Human immunodeficiency virus type 1 (HIV-1) RNA; Human immunodeficiency virus type 2 (HIV-2) RNA |
| Plasma | Hepatitis B virus (HBV) DNA; Hepatitis C virus (HCV) viral RNA; Human immunodeficiency virus type 1 (HIV-1) RNA; Human immunodeficiency virus type 2 (HIV-2) RNA | |
| Plasma; Serum | Hepatitis B virus (HBV) DNA; Hepatitis C virus (HCV) viral RNA; Human immunodeficiency virus type 1 (HIV-1) RNA; Human immunodeficiency virus type 2 (HIV-2) RNA | |
| Microbiology - Serology of infection - Microbial antibody and/or antigen detection and/or quantitation | Cadaveric blood | Hepatitis B virus surface antigen (HBs Ag); Hepatitis C virus (HCV); Human T-lymphotropic virus type I/II (HTLV-I/II); Human immunodeficiency virus (HIV) p24 antigen; Human immunodeficiency virus type 1/2 (HIV-1/2) 1/2 antibodies; Syphilis Treponema pallidum antibody |
| Plasma | Plasmodium falciparum antibody; Plasmodium vivax antibody | |
| Plasma; Serum | Hepatitis B virus surface antigen (HBs Ag); Hepatitis C virus (HCV); Human T-lymphotropic virus type I/II (HTLV-I/II); Human immunodeficiency virus (HIV) p24 antigen; Human immunodeficiency virus type 1/2 (HIV-1/2) 1/2 antibodies; Syphilis Treponema pallidum antibody | |
| Cytomegalovirus (CMV) |
The only data displayed is that deemed relevant and necessary for the clear description of the activities and services covered by the scope of accreditation.
Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.
Accreditation No.
18808
Site No.
22664
Print date
07 Jun 2026
END OF SCOPE